Investigational Site Number :6160009

Grudziądz, Kuyavian-Pomeranian Voivodeship 86-300

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed